Valuation : Novartis AG

Market Cap 26TCr 23TCr 21TCr 19TCr 36TCr 24,92500Cr 36TCr 2,51500Cr 97TCr 12,69800Cr 98TCr 96TCr 40,22800Cr P/E 2026 *
19.5x
P/E 2027 * 16.5x
Enterprise Value 29TCr 25TCr 24TCr 22TCr 41TCr 28,05000Cr 41TCr 2,83100Cr 1,09400Cr 14,29000Cr 1,10700Cr 1,08300Cr 45,27200Cr EV / Sales 2026 *
5.11x
EV / Sales 2027 * 4.73x
Free-Float
91.66%
Yield 2026 *
3.2%
Yield 2027 * 3.34%
1 day-0.13%
1 week-14.97%
Current month-9.41%
1 month-11.37%
3 months-5.68%
6 months-10.89%
Current year+1.88%
1 week 110.3
Extreme 110.3
130.86
1 month 110.3
Extreme 110.3
132.68
Current year 107.68
Extreme 107.68
132.68
1 year 96.03
Extreme 96.03
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-14.97%+9.41%+26.71% 26TCr
+0.03%-3.09%+49.77%+91.69% 1,00200Cr
-0.76%-2.95%+50.93%+66.34% 65TCr
+0.86%-4.13%+19.24%+68.37% 44TCr
-0.80%-0.43%+28.92%+35.45% 35TCr
-1.90%-2.72%-2.72%+7.41% 25TCr
-0.48%-11.65%+39.75%+50.82% 21TCr
-1.06%-4.23%-14.70%-57.36% 20TCr
-0.68%-2.65%+25.82%+91.64% 18TCr
-0.04%-4.27%+12.42%-18.89% 16TCr
Average -0.50%-4.40%+21.88%+36.22% 37.02TCr
Weighted average by Cap. -0.40%-3.90%+31.15%+53.76%

Financials

2026 *2027 *
Net sales 5.76TCr 4.96TCr 4.67TCr 4.26TCr 7.96TCr 5,48500Cr 7.99TCr 55TCr 21TCr 2,79400Cr 22TCr 21TCr 8,85200Cr 6.13TCr 5.28TCr 4.97TCr 4.53TCr 8.47TCr 5,83500Cr 8.5TCr 59TCr 23TCr 2,97200Cr 23TCr 23TCr 9,41700Cr
Net income 1.42TCr 1.22TCr 1.15TCr 1.05TCr 1.96TCr 1,35000Cr 1.97TCr 14TCr 5.27TCr 69TCr 5.33TCr 5.21TCr 2,17900Cr 1.57TCr 1.36TCr 1.28TCr 1.16TCr 2.18TCr 1,49800Cr 2.18TCr 15TCr 5.84TCr 76TCr 5.91TCr 5.78TCr 2,41800Cr
Net Debt 3.28TCr 2.83TCr 2.66TCr 2.42TCr 4.54TCr 3,12500Cr 4.55TCr 32TCr 12TCr 1,59200Cr 12TCr 12TCr 5,04400Cr 2.79TCr 2.4TCr 2.26TCr 2.06TCr 3.85TCr 2,65400Cr 3.87TCr 27TCr 10TCr 1,35200Cr 10TCr 10TCr 4,28400Cr
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
09/26/09 CHF 111.66 -0.13% 43,17,913
08/26/08 CHF 111.80 -10.89% 1,04,30,648
07/26/07 CHF 125.46 -3.18% 31,16,102
04/26/04 CHF 129.58 -1.33% 26,16,060
03/26/03 CHF 131.32 0.00% 32,48,432
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
137.81USD
Average target price
153.34USD
Spread / Average Target
+11.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!